Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Endocrinology

The Diagnostic Pathway for Nodular Goiter: Tests and Imaging

At a Glance

Nodular goiter evaluation starts with a TSH blood test and thyroid ultrasound. A low TSH may prompt a specialized thyroid scan, while nodule size, ultrasound features, and suspicious lymph nodes help determine whether FNA or follow-up is needed.

When a nodular goiter is suspected, doctors follow a standardized “map” to determine what the nodules are and whether they affect your health. This process is designed to find the small percentage of nodules that are cancerous or overactive while avoiding unnecessary procedures for the majority that are benign [1][2].

The First Step: The TSH Blood Test

The very first diagnostic step is a blood test to measure Thyroid-Stimulating Hormone (TSH) [1]. This hormone is the brain’s way of telling the thyroid how much work to do. Because TSH is a screening test, an abnormal result usually requires checking free T4 and T3 levels.

The TSH result acts as a fork in the road for your diagnosis:

  • Low TSH: This suggests your thyroid is overactive. This could be due to “toxic” autonomous nodules, but can also be caused by temporary thyroiditis or medications [3]. This usually leads to a specialized scan (scintigraphy) to check for autonomous nodules [1].
  • Normal or High TSH: This is more common. A normal TSH makes an autonomously functioning nodule less likely, while a high TSH suggests an underactive thyroid [4]. In this case, the focus shifts entirely to the appearance of the nodules on an ultrasound [2].

Ultrasound and Risk Scoring (TI-RADS)

A dedicated thyroid ultrasound is the gold standard for looking at the physical structure of your nodules [1]. Because almost everyone develops some nodules as they age, doctors use standardized risk-stratification systems like ACR TI-RADS (Thyroid Imaging, Reporting and Data System) to decide which ones are suspicious [5]. These systems are aids to help estimate risk, not definitive cancer diagnoses.

Under the TI-RADS system, a radiologist gives the nodule “points” based on five features [5][6]:

  1. Composition: Is it solid (more points) or filled with fluid (cystic)? Cystic or “spongiform” nodules are almost always benign [6].
  2. Echogenicity: How dark does it look compared to normal tissue? Darker (hypoechoic) nodules get more points.
  3. Shape: Is it “taller than wide”? This orientation is a suspicious feature [6].
  4. Margins: Are the edges smooth or irregular/jagged?
  5. Echogenic Foci: Are there tiny bright spots (microcalcifications) inside?

The total points determine a score from TR1 (benign) to TR5 (highly suspicious). This score, combined with the size of the nodule and any suspicious lymph nodes, tells your doctor if a Fine-Needle Aspiration (FNA) biopsy is needed or if the nodule can simply be watched over time [5][7].

Radionuclide (Nuclear) Scans

If your TSH was low, your doctor will order a thyroid scintigraphy (radionuclide scan). You receive a tiny amount of a radioactive tracer, and a camera maps where your thyroid absorbs it [1]. (Note: These scans are generally avoided during pregnancy and breastfeeding. Recent exposure to iodine contrast from CT scans or certain supplements can also interfere with the results, so inform your doctor if this applies to you.)

  • “Hot” Nodules: These nodules absorb more tracer than the rest of the gland. They are overactive and producing hormone [3]. Crucially, “hot” nodules have a much lower likelihood of being cancer and frequently do not require a biopsy, though risk is never zero and ultrasound findings still matter [8][9].
  • “Cold” Nodules: These nodules do not absorb the tracer. While most cold nodules are still benign, they have a higher relative risk of being cancerous compared to hot ones and are evaluated using the ultrasound criteria mentioned above [10][9].

When are CT or MRI Used?

Routine CT or MRI scans are generally not used for thyroid nodules because they cannot show the fine details needed to assess cancer risk as well as an ultrasound can [1][2]. However, your doctor might order one if your goiter is very large, if it appears to be growing downward behind your breastbone (substernal extension), or if it is significantly narrowing your windpipe [11][12][13].

Common questions in this guide

What is the first test for a nodular goiter?
The first test is usually a blood test for thyroid-stimulating hormone, or TSH. If TSH is abnormal, clinicians commonly check free T4 and T3; a low TSH may lead to a radionuclide scan, while a normal or high TSH usually shifts attention to ultrasound.
What does a TI-RADS score mean for a thyroid nodule?
TI-RADS is an ultrasound scoring system that estimates how suspicious a thyroid nodule looks. The score ranges from TR1, which is considered benign, to TR5, which is highly suspicious. The score is not a cancer diagnosis; its meaning is considered along with the nodule's size and any suspicious lymph nodes.
When is a radionuclide thyroid scan needed?
A radionuclide, or nuclear, thyroid scan is generally considered when the TSH level is low. It shows whether a nodule is absorbing more tracer than the rest of the gland or absorbing little or none. These scans are generally avoided during pregnancy and breastfeeding, and recent iodine contrast or certain supplements can affect the results.
Does a hot thyroid nodule need a biopsy?
A hot nodule absorbs more tracer and produces thyroid hormone, and it has a much lower likelihood of being cancerous than a cold nodule. Hot nodules often do not need a biopsy, but the risk is not zero, so ultrasound findings and the overall clinical picture still matter.
How is it decided whether a thyroid nodule needs an FNA biopsy?
The decision is based on the nodule's ultrasound appearance and TI-RADS score, its size, and whether there are suspicious lymph nodes. TSH results and, when appropriate, a thyroid scan also help guide the next step. Some nodules need fine-needle aspiration, while others can be monitored.
When are CT or MRI scans used for nodular goiter?
CT or MRI is not routinely used to assess the fine details of thyroid nodules because ultrasound is better suited for that purpose. A clinician may order one when the goiter is very large, extends behind the breastbone, or significantly narrows the windpipe.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my TSH levels, do I need a radionuclide (scintigraphy) scan before considering a biopsy?
  2. 2.What is the TI-RADS score for each of my nodules, and what specific features led to that score?
  3. 3.If you are recommending a biopsy (FNA), is it because of the size of the nodule or its appearance on the ultrasound?
  4. 4.Are there any signs that my goiter is extending behind my breastbone (substernal extension)?
  5. 5.If my nodules are 'cold' on a scan, what are the next steps for monitoring or testing them?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Thyroid nodules: diagnosis and management.

    Wong R, Farrell SG, Grossmann M

    The Medical journal of Australia 2018; (209(2)):92-98 doi:10.5694/mja17.01204.

    PMID: 29996756
  2. 2

    Thyroid and Parathyroid Conditions: Thyroid Nodules, Cysts, and Malignancies.

    Adams CS, Bragg S, Christian N, Rhodes MA

    FP essentials 2022; (514()):24-29.

    PMID: 35235283
  3. 3

    Molecular Imaging for Thyrotoxicosis and Thyroid Nodules.

    Giovanella L, Avram A, Clerc J

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2021; (62(Suppl 2)):20S-25S doi:10.2967/jnumed.120.246017.

    PMID: 34230069
  4. 4

    Management of Thyroid Nodules.

    Uludag M, Unlu MT, Kostek M, et al.

    Sisli Etfal Hastanesi tip bulteni 2023; (57(3)):287-304 doi:10.14744/SEMB.2023.06992.

    PMID: 37900341
  5. 5

    Comparison of Performance Characteristics of American College of Radiology TI-RADS, Korean Society of Thyroid Radiology TIRADS, and American Thyroid Association Guidelines.

    Middleton WD, Teefey SA, Reading CC, et al.

    AJR. American journal of roentgenology 2018; (210(5)):1148-1154 doi:10.2214/AJR.17.18822.

    PMID: 29629797
  6. 6

    Retrospective Application of the 2015 American Thyroid Association Guidelines for Ultrasound Classification, Biopsy Indications, and Follow-up Imaging of Thyroid Nodules: Can Improved Reporting Decrease Testing?

    Mohammadi M, Betel C, Burton KR, et al.

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2019; (70(1)):68-73 doi:10.1016/j.carj.2018.09.001.

    PMID: 30691566
  7. 7

    Comparison of Thyroid Risk Categorization Systems and Fine-Needle Aspiration Recommendations in a Multi-Institutional Thyroid Ultrasound Registry.

    Hoang JK, Middleton WD, Langer JE, et al.

    Journal of the American College of Radiology : JACR 2021; (18(12)):1605-1613 doi:10.1016/j.jacr.2021.07.019.

    PMID: 34419476
  8. 8

    Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis.

    Lau LW, Ghaznavi S, Frolkis AD, et al.

    Thyroid research 2021; (14(1)):3 doi:10.1186/s13044-021-00094-1.

    PMID: 33632297
  9. 9

    Thyroid Nodules: Advances in Evaluation and Management.

    Kant R, Davis A, Verma V

    American family physician 2020; (102(5)):298-304.

    PMID: 32866364
  10. 10

    Distribution of Functional Status of Thyroid Nodules and Malignancy Rates of Hyperfunctioning and Hypofunctioning Thyroid Nodules in Germany.

    Schenke SA, Kreissl MC, Grunert M, et al.

    Nuklearmedizin. Nuclear medicine 2022; (61(5)):376-384 doi:10.1055/a-1856-4052.

    PMID: 35917825
  11. 11

    Thyroid storm triggered by thyroid nodule fine needle aspiration biopsy: a case report.

    Eatz TA, Rios P, Penaherrera Oviedo CA, Lagari V

    AME case reports 2024; (8()):15 doi:10.21037/acr-23-63.

    PMID: 38234357
  12. 12

    Adenoid Cystic Carcinoma of the Larynx Presenting as a Thyroid Mass and Brief Literature Review.

    Shirian S, Maghbool M, Aledavood A, et al.

    Acta cytologica 2017; (61(3)):237-241 doi:10.1159/000464271.

    PMID: 28490006
  13. 13

    Malignant teratoma of the thyroid: A difficult diagnosis by fine-needle aspiration.

    Starling CE, Sabra J, Brady B, et al.

    Diagnostic cytopathology 2019; (47(9)):930-934 doi:10.1002/dc.24216.

    PMID: 31120625

This page is for informational purposes only and does not constitute medical advice. Your clinician should interpret your TSH, ultrasound, and scan results in the context of your health.

Get notified when new evidence is published on nodular goiter.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.